Skip to search formSkip to main contentSkip to account menu

ATP7B gene

Known as: ATP7B, ATPase, Cu(2+)-TRANSPORTING, BETA POLYPEPTIDE, ATPase copper transporting beta 
National Institutes of Health

Related topics

Related topics

2 relations
Hepatolenticular DegenerationWilson disease protein

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
The genetics of Wilson disease.
Highly Cited
2016
Highly Cited
2016
Spectrum and Classification of ATP7B Variants in a Large Cohort of Chinese Patients with Wilson's Disease Guides Genetic Diagnosis
Background: Wilson's disease (WD) is an autosomal recessive disorder of copper metabolism caused by ATP7B pathogenic mutations… 
Highly Cited
2015
Highly Cited
2015
Hepatic steatosis in Wilson disease--Role of copper and PNPLA3 mutations.
Review
2014
Review
2014
Modifying factors and phenotypic diversity in Wilson's disease
Wilson's disease (WD) is a human disorder of copper homeostasis caused by mutations in the copper‐transporting ATPase ATP7B. WD… 
Review
2013
Review
2013
A review and current perspective on Wilson disease.
Highly Cited
2013
Highly Cited
2013
Efficacy and safety of oral chelators in treatment of patients with Wilson disease.
Review
2013
Review
2013
Role of the P-Type ATPases, ATP7A and ATP7B in brain copper homeostasis
Over the past two decades there have been significant advances in our understanding of copper homeostasis and the pathological… 
Highly Cited
2013
Highly Cited
2013
Hepatobiliary malignancies in Wilson disease
Reports of hepatobiliary malignancies in Wilson disease are sparse. The aim of this study was to evaluate hepatobiliary… 
2010
2010
Involvement of Protein Kinase D in Expression and Trafficking of ATP7B (Copper ATPase)*
ATP7B is a P-type ATPase involved in copper transport and homeostasis. In experiments with microsomes isolated from COS-1 cells… 
Highly Cited
2001
Highly Cited
2001
Expression and cisplatin sensitivity of copper-transporting P-type adenosine triphosphatase (ATP7B) in human solid carcinoma cell lines.
One of the most important clinical problems in the treatment of human solid carcinoma is the intrinsic/acquired resistance… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)